FOLLOW US

  • facebook
  • twitter
Mon

March 30, 2026

America July 18, 2023

Revolutionary Alzheimer’s Drug, Donanemab, Shows Promise in Slowing Disease Progression

In a groundbreaking development, Eli Lilly, a US-based pharmaceutical company, has released the final results of trials on donanemab, a…

By Jackie Allen

America June 19, 2023

A groundbreaking research study conducted by the University of Haifa and the Max Stern Yezreel Valley College in Israel has…

By Jackie Allen

Signup for the USA Herald
exclusive Newsletter